ClassID:

94568

C07D245/02 - CPC Classification

Classification description:

Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings

Recent Application in this class:
#1
20260069604
2026-03-12

NOVEL EQUILIBRATIVE NUCLEOSIDE TRANSPORTER INHIBITORS AND METHODS OF MAKING AND USING SAME

#2
20250099384
2025-03-27

THIOESTER CATIONIC LIPIDS

#3
20250025443
2025-01-23

COMPOUNDS AND METHODS FOR TREATING CORONA VIRUSES

#4
20230312431
2023-10-05

COMPOUNDS AND PREPARATION METHOD THEREFOR AND USE THEREOF AS ENERGETIC MATERIALS

#5
20230174562
2023-06-08

RADIO-AND CHEMO-PROTECTIVE COMPOUNDS

#6
20220008338
2022-01-13

Thioester cationic lipids

#7
20210009533
2021-01-14

Methods for 1,4-diazo N-heterocycle synthesis

#8
20200216401
2020-07-09

NOVEL SYRINGOLIN ANALOGUES AND METHODS OF MAKING AND USING SAME

#9
20200199067
2020-06-25

Hydrogen sulfide donor in organic salt form and preparation method therefor

#10
20190055205
2019-02-21

Methods for 1,4-diazo n-heterocycle synthesis

#11
20190010133
2019-01-10

Syringolin analogues and methods of making and using same

#12
20190009258
2019-01-10

High charge density metallophosphate molecular sieves

#13
20160347790
2016-12-01

Synthesis of syrbactin proteasome inhibitors

#14
20160246173
2016-08-25

Composition of matter and molecular resist made therefrom

#15
20160108007
2016-04-21

Synthesis of syrbactin proteasome inhibitors

#16
20160024024
2016-01-28

Choline kinase inhibitors

#17
20150336915
2015-11-26

STRUCTURES OF PROTEASOME INHIBITORS AND METHODS FOR SYNTHESIZING AND USE THEREOF

#18
20150322079
2015-11-12

LOW CATALYST LOADING IN METATHESIS REACTIONS

#19
20150246348
2015-09-03

Z-selective ring-closing metathesis reactions

#20
20150141392
2015-05-21

Substituted macrocyclic compounds having proteasome inhibitory activity

#21
20150140489
2015-05-21

Composition of matter and molecular resist made therefrom

#22
20140288059
2014-09-25

Therapeutic compositions and methods

#23
20140187526
2014-07-03

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CONDITIONS RESPONSIVE TO PROTEASOME INHIBITION

#24
20140093450
2014-04-03

Pretargeting kit for imaging or therapy comprising a trans-cyclooctene dienophile and a diene

#25
20130324687
2013-12-05

Compounds, monomers, and polymers containing a carbonate linkage

#26
20130089522
2013-04-11

Heterologous hosts

#27
20130065872
2013-03-14

Synthesis of syrbactin proteasome inhibitors

#28
20120323000
2012-12-20

-selective ring-closing metathesis reactions

#29
20120108562
2012-05-03

Therapeutic compositions and methods

#30
20110237755
2011-09-29

Method of using a cyclic carbodiimide

#31
20100267070
2010-10-21

Pharmaceutical compositions for the treatment of conditions responsive to proteasome inhibition

#32
20100160626
2010-06-24

Process For The Preparation Of 3,7-Dihydroxy-1,5-Diazacyclooctanes

#33
20100063013
2010-03-11

CATHEPSIN CYSTEINE PROTEASE INHIBITORS

#34
20100022767
2010-01-28

DEVELOPMENT OF A SYNTHESIS OF SYRINGOLIN A AND B AND DERIVATIVES THEREOF

#35
20100022500
2010-01-28

Macrocyclic Lactams and Pharmaceutical Use Thereof

#36
20090203631
2009-08-13

PEPTIDE DEFORMYLASE INHIBITORS AS NOVEL ANTIBIOTICS

#37
20090170878
2009-07-02

MACROCYCLIC COMPOUNDS USEFUL AS BACE INHIBITORS

#38
20090054460
2009-02-26

Piperazine derivatives and methods of use

#39
20070259812
2007-11-08

Peptide deformylase inhibitors as novel antibiotics

#40
20070072792
2007-03-29

Macrocyclic lactams and pharmaceutical use thereof

#41
20050113424
2005-05-26

Arylamidine derivative or salt thereof

#42
20050026821
2005-02-03

Peptide deformylase inhibitors as novel antibiotics

#43
20050014749
2005-01-20

Piperazine derivatives and methods of use